Artificial intelligence in Medicare: utilization, spending, and access to AI-enabled clinical software.
Journal:
The American journal of managed care
PMID:
38820190
Abstract
OBJECTIVES: In 2018, CMS established reimbursement for the first Medicare-covered artificial intelligence (AI)-enabled clinical software: CT fractional flow reserve (FFRCT) to assist in the diagnosis of coronary artery disease. This study quantified Medicare utilization of and spending on FFRCT from 2018 through 2022 and characterized adopting hospitals, clinicians, and patients.